PATRICIA POWERS: Open Payments
NPI 1396012399 · GREENBRIER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 55 payments from 18 companies in 2025. Trend: 2023 $1,283 · 2024 $755 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $252 |
| ABBVIE INC. | 9 | $183 |
| AstraZeneca Pharmaceuticals LP | 10 | $169 |
| Novo Nordisk Inc | 7 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Astellas Pharma US Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| PFIZER INC. | 2 | $47 |
| Abbott Laboratories | 2 | $45 |
| Exact Sciences Corporation | 2 | $42 |
Products named: CAPLYTA, Ozempic, AIRSUPRA, VRAYLAR, Kerendia, QULIPTA, Veozah, REXULTI.
Industry payments across TN — which companies pay providers there.
